Disc Medicine (IRON) Gains from Sales and Divestitures (2021 - 2025)
Disc Medicine (IRON) reported Gains from Sales and Divestitures of $117911.0 for Q4 2025, up 6054.02% on a QoQ basis from $1916.0 in Q4 2023.
Disc Medicine (IRON) has 4 years of Gains from Sales and Divestitures data on file, last reported at $117911.0 in Q4 2025.
- Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $117911.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $117911.0 (changed N/A YoY) and the FY2025 annual result came in at $117911.0, changed N/A from the prior year.
- Gains from Sales and Divestitures advanced to $117911.0 in Q4 2025 per IRON's latest filing, from $1916.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $117911.0 in Q4 2025 and bottomed at $958.0 in Q1 2023.
- The 4-year median for Gains from Sales and Divestitures is $3427.5 (2022), against an average of $16135.0.
- The widest annual swing landed in 2022, when Gains from Sales and Divestitures plunged 44.12%; it then slumped 76.79% in 2023.
- Tracing IRON's Gains from Sales and Divestitures over 4 years: stood at $14770.0 in 2021, then tumbled by 44.12% to $8254.0 in 2022, then tumbled by 76.79% to $1916.0 in 2023, then soared by 6054.02% to $117911.0 in 2025.
- Per Business Quant, the three latest IRON Gains from Sales and Divestitures figures stand at $117911.0 (Q4 2025), $1916.0 (Q4 2023), and $1916.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 117,911.00 |
| Dec 31, 2025 | 117,911.00 |
| Dec 31, 2023 | 1,916.00 |
| Dec 31, 2023 | 1,916.00 |
| Sep 30, 2023 | 1,916.00 |
| Sep 30, 2023 | 1,916.00 |
| Jun 30, 2023 | 1,916.00 |
| Jun 30, 2023 | 1,916.00 |
| Mar 31, 2023 | 958.00 |
| Mar 31, 2023 | 958.00 |
| Dec 31, 2022 | 8,254.00 |
| Dec 31, 2022 | 8,254.00 |
| Sep 30, 2022 | 6,854.00 |
| Sep 30, 2022 | 6,854.00 |
| Jun 30, 2022 | 4,570.00 |
| Jun 30, 2022 | 4,570.00 |
| Mar 31, 2022 | 2,285.00 |
| Mar 31, 2022 | 2,285.00 |
| Dec 31, 2021 | 14,770.00 |
| Dec 31, 2021 | 14,770.00 |